Russell Investments Group, Ltd. Oncolytics Biotech Inc Transaction History
Russell Investments Group, Ltd.
- $75.4 Billion
- Q2 2025
A detailed history of Russell Investments Group, Ltd. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1 shares of ONCY stock, worth $1. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$1% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ONCY
# of Institutions
57Shares Held
1.44MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL207KShares$246,2110.01% of portfolio
-
Seeds Investor LLC New York, NY190KShares$226,0290.03% of portfolio
-
Goldman Sachs Group Inc New York, NY130KShares$154,9350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$79,6570.0% of portfolio
-
Commonwealth Equity Services, LLC65.1KShares$77,4850.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $68.9M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...